Profile of people with diabetes who used telepharmacy during the covid-19 pandemic: results from DIABETESvid

• Autor(a) principal: Alcantara, Paulo Sérgio Gonçalves de
• Data de Publicação: 2023
• Outros Autores: Almeida-Pititto, Bianca de, Teixeira, Carla Regina de Souza, Binhardi, Bárbara Aparecida, Barbosa-Junior, Francisco, Franco, Laercio Joel, Melo, Karla Fabiana Santana de, Malerbi, Domingos Augusto Cherino, Oliveira, Rinaldo Eduardo Machado de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: RECIIS (Online)
• Texto Completo: https://www.reciis.icict.fiocruz.br/index.php/reciis/article/view/3375
• topic: Diabetes mellitus tipo 1; Diabetes mellitus tipo 2; Covid-19; Estratégias de e-saúde; Serviços comunitários de farmácia; Diabetes mellitus type 1; Diabetes mellitus type 2; Covid-19; e-Health strategies; Community pharmacy services; Diabetes mellitus tipo 1; Diabetes mellitus tipo 2; Covid-19; Estrategias de e-salud; Servicios comunitarios de farmacia

The objective was to analyze the profile of people with diabetes who used telepharmacy during the covid-19 pandemic. This is a cross-sectional study with data from the DIABETESvid websurvey that took place in September and October 2020. It was found that 45 participants used telepharmacy, 55.6% of whom were male, 42.2% were between 18 and 34 years-old and 46.7% studied 12 or more years. In addition, 48.9% self-reported type 1 diabetes mellitus. Most used insulin (55.6%) and obtained their diabetes medication from pharmacies in the public health system (60%). Also, people diagnosed with covid-19 used telepharmacy more often (PR=2.20; 95%CI 1.23–3.94). It is known that drugs are essential for the treatment of diabetes. Therefore, in the period studied in which physical distancing was advocated, the participants used telepharmacy to obtain comprehensive care.